Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
945
+5
+0.5% +$1.08K 0.06% 93
2026
Q1
$204K Sell
940
-27
-3% -$5.99K 0.06% 85
2025
Q4
$221K Sell
967
-53
-5% -$12.1K 0.07% 79
2025
Q3
$236K Buy
+1,020
New +$208K 0.08% 77
2025
Q2
Sell
-1,020
Closed -$214K 88
2025
Q1
$214K Buy
+1,020
New +$198K 0.09% 79
2024
Q4
Sell
-1,020
Closed -$201K 83
2024
Q3
$201K Sell
1,020
-308
-23% -$57.5K 0.09% 84
2024
Q2
$228K Sell
1,328
-130
-9% -$21.5K 0.11% 70
2024
Q1
$266K Hold
1,458
0.14% 62
2023
Q4
$226K Sell
1,458
-7
-0.5% -$1.02K 0.14% 68
2023
Q3
$218K Sell
1,465
-78
-5% -$11.5K 0.15% 62
2023
Q2
$208K Buy
1,543
+84
+6% +$12.3K 0.15% 71
2023
Q1
$233K Sell
1,459
-53
-4% -$8.1K 0.2% 62
2022
Q4
$244K Buy
+1,512
New +$232K 0.26% 56

Other funds holding ABBV

Sensible Money's ABBV Position: Q2 2026 in Review

Sensible Money increased its AbbVie (ABBV) stake by 0.53% in Q2 2026, buying an estimated $1.08K and bringing the position to 945 shares worth $238K. The position accounts for 0.06% of the portfolio, ranked #93.

Sensible Money first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. The position peaked at $266K in Q1 2024. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sensible Money held 945 shares of AbbVie worth $238K as of Q2 2026.
  • Sensible Money bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
  • AbbVie made up 0.06% of Sensible Money's portfolio in Q2 2026, its #93 holding.
  • Sensible Money first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
  • Sensible Money's AbbVie position peaked at $266K in Q1 2024.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sensible Money's 13F filing for Q2 2026, filed 30 Jul 2026.